🧬 Ready to boost confidence in your #NGS workflows?
Join @HyraxBio’s webinar on how #Exatype strengthens analytical validation using examples of #HIV, #Mtb & #RespiratoryPanel Data
📅 Nov 19 08:00 PST → https://t.co/oOtmu4csuX
📅 Nov 25 10:00 CET → https://t.co/IuZctOsiWC
#SARSCoV2 and the #COVID19 pandemic made it clear: *test test test*! To ensure healthy lives and achieve the @SDGoals, #HIV and #TB testing is a global priority. @hyraxbio supports equitable testing & access to treatment through #Exatype https://t.co/zprCFUaWgN #NGS#sequencing
🆕Rapid expansion of genomics surveillance of SARS-CoV-2 variants shows the power of African science🌍🧬 #AfricaGenomics#AfricaPGI
The collaborative team includes nine Quadram researchers. Read more about our involvement in the global sequencing effort
➡️https://t.co/1capBYkE4K
Germline targeting is a major focus in HIV vaccine design. Scheepers et al show that for an MPER-directed antibody, convergent evolution & shared germline gene usage may not be enough to achieve neutralization breadth.
@CathrineSch07@PennyMo70026063
https://t.co/Cvnb5pKXDz
@kallmemeg@PeacockFlu@TheSecretSarah@Rajeev_The_King As with many countries testing and sequencing is lower than previous months but we’re still doing both. Wastewater results also show low amounts of SARS-CoV-2 throughout the country. But we’ll continue to monitor and will ramp up efforts if there are any signs of increases.
@almos6661@Tuliodna No reason to panic. We see it in very low numbers. We’ve also seen recombinants across the globe before and they haven’t had much impact. This could be the same. However we will continue to monitor it very closely and keep everyone informed.
XAY designated (note: only cluster 1). Cluster 2 will remain open for watching.
Excellent work from NGS-SA for picking it up and flagging!
https://t.co/zSRjLl5lrI
Yesterday was my last day of working at Google. Perhaps this comes as surprise to you twitter folks, as I haven't widely announced that I left academia to try something new. Here's what I learned in 9 months as a Data Analyst who (temporarily) left Astronomy for Big Tech. 1/n